B. Šeol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
B. Šeol has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
K. Matanović
Department of Microbiology and Infectious Diseases with Clinic Faculty of Veterinary Medicine University of Zagreb Heinzelova 55 10000 Zagreb Croatia
1 shared publicationS. Mekić
Department of Microbiology and Infectious Diseases with Clinic, Faculty of Veterinary Medicine, University of Zagreb, Heinzelova 55, 10000 Zagreb, Croatia
1 shared publication
Latest Publications
- Open Access
- 30 July 2011
- Published by Wiley in Veterinary Record
- Vol. 169 (5) , 125
Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa
Pseudomonas aeruginosa is a common cause of otitis externa in dogs, and treatment of these infections is becoming problematic because of the increasing number of multiresistant strains. The aim of the present study was to compare the in vitro activities of cefepime, ceftazidime, enrofloxacin, ciprofloxacin, gentamicin and ticarcillin/clavulanic acid against 104 strains of P aeruginosa isolated from dogs with otitis externa. Antimicrobial susceptibility and minimum inhibitory concentrations, in µg/ml, were evaluated by the E test (bioMérieux). The most active compound was ceftazidime, with 100 per cent efficiency. The majority of tested strains were susceptible to ticarcillin/clavulanic acid (89.4 per cent), followed by ciprofloxacin (88.5 per cent) and cefepime (60.6 per cent). The highest resistance was observed to enrofloxacin (51.9 per cent) and gentamicin (43.3 per cent). Large numbers of strains were intermediately susceptible to antibiotics registered for use in veterinary medicine in Croatia – enrofloxacin (47.1 per cent) and gentamicin (41.3 per cent).
- 30 July 2011
- Published by Wiley in Veterinary Record
- Vol. 169 (5) , 125
Open AccessAntimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa
Pseudomonas aeruginosa is a common cause of otitis externa in dogs, and treatment of these infections is becoming problematic because of the increasing number of multiresistant strains. The aim of the present study was to compare the in vitro activities of cefepime, ceftazidime, enrofloxacin, ciprofloxacin, gentamicin and ticarcillin/clavulanic acid against 104 strains of P aeruginosa isolated from dogs with otitis externa. Antimicrobial susceptibility and minimum inhibitory concentrations, in µg/ml, were evaluated by the E test (bioMérieux). The most active compound was ceftazidime, with 100 per cent efficiency. The majority of tested strains were susceptible to ticarcillin/clavulanic acid (89.4 per cent), followed by ciprofloxacin (88.5 per cent) and cefepime (60.6 per cent). The highest resistance was observed to enrofloxacin (51.9 per cent) and gentamicin (43.3 per cent). Large numbers of strains were intermediately susceptible to antibiotics registered for use in veterinary medicine in Croatia – enrofloxacin (47.1 per cent) and gentamicin (41.3 per cent).